$FHLD
Freedom Holdings, Inc.

2024 Q1 Form 10-Q Financial Statement

#000147793224000824 Filed on February 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $72.00 $65.00
YoY Change -96.95% -96.5%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $14.57K $360.00
YoY Change -48.96% -83.14%
Operating Profit -$14.57K -$360.00
YoY Change -48.96% -83.14%
Interest Expense $2.863K $2.894K
YoY Change -2.82% -5.55%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$17.44K -$3.254K
YoY Change -44.64% -37.41%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 55.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $21.00 $93.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $21.00 $93.00
YoY Change -99.72% -35.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $21.00 $93.00
Total Long-Term Assets $0.00 $0.00
Total Assets $21.00 $93.00
YoY Change -99.72% -35.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $47.66K $45.66K
YoY Change -18.79% 3.34%
Accrued Expenses $240.0K $240.0K
YoY Change -0.92% -1.22%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $304.7K $288.9K
YoY Change -9.76% -11.68%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $304.7K $288.9K
Total Long-Term Liabilities
Total Liabilities $431.1K $415.2K
YoY Change 1.07% -0.62%
SHAREHOLDERS EQUITY
Retained Earnings -$10.20M -$10.18M
YoY Change 3.91% 4.07%
Common Stock $5.631K $5.531K
YoY Change 14.2% 494.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$431.1K -$415.1K
YoY Change
Total Liabilities & Shareholders Equity $21.00 $93.00
YoY Change -99.72% -35.86%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$17.44K -$3.254K
YoY Change -44.64% -37.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$495.00
YoY Change -92.23%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$495.00
Cash From Investing Activities
Cash From Financing Activities $0.00
Net Change In Cash -$495.00
YoY Change 1446.88%
FREE CASH FLOW
Cash From Operating Activities -$495.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Assets Current
AssetsCurrent
588 usd
CY2023Q3 us-gaap Assets
Assets
588 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
44500 usd
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
330 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
241297 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55308825 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55308825 shares
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001386044
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Security12g Title
Security12gTitle
Common Stock, $0.0001 par value
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
000-54853
CY2023Q4 dei Entity Registrant Name
EntityRegistrantName
FREEDOM HOLDINGS, INC.
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2560951
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
10524 Independence Ave
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Chatsworth
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91311
CY2023Q4 dei City Area Code
CityAreaCode
818
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
357-3155
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55308825 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
588 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
93 usd
CY2023Q4 us-gaap Assets
Assets
93 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
45662 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
3224 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
240000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
288886 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
286127 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
126350 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
126350 usd
CY2023Q4 us-gaap Liabilities
Liabilities
415236 usd
CY2023Q3 us-gaap Liabilities
Liabilities
412477 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5531 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5531 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9765828 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9765828 usd
CY2023Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
5500 usd
CY2023Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
5500 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10181002 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10177748 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-415143 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-411889 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
588 usd
CY2023Q4 us-gaap Revenues
Revenues
0 usd
CY2022Q4 us-gaap Revenues
Revenues
0 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
295 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
278 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1857 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
360 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
2135 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-360 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2135 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
2894 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
3064 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-3254 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-5199 usd
CY2023Q4 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.00
CY2022Q4 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.00
CY2023Q4 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
55308825 shares
CY2022Q4 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
9308825 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-412471 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-5199 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-417670 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-411889 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-3254 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-415143 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-3254 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-5199 usd
CY2023Q4 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-135 usd
CY2022Q4 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-1196 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2894 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
24 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-495 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6371 usd
CY2023Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2022Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
6339 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6339 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-495 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
3064 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd

Files In Submission

Name View Source Status
0001477932-24-000824-index-headers.html Edgar Link pending
0001477932-24-000824-index.html Edgar Link pending
0001477932-24-000824.txt Edgar Link pending
0001477932-24-000824-xbrl.zip Edgar Link pending
fhld-20231231.xsd Edgar Link pending
fhld_10q.htm Edgar Link pending
fhld_ex311.htm Edgar Link pending
fhld_ex312.htm Edgar Link pending
fhld_ex321.htm Edgar Link pending
fhld_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
fhld-20231231_cal.xml Edgar Link unprocessable
fhld-20231231_def.xml Edgar Link unprocessable
fhld-20231231_lab.xml Edgar Link unprocessable
fhld_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fhld-20231231_pre.xml Edgar Link unprocessable